Altria sells U.S. IQOS rights to Philip Morris for $2.7 billion
Reuters
Published Oct 19, 2022 06:37PM ET
Updated Oct 20, 2022 06:50AM ET
(Reuters) -U.S. cigarette maker Altria Group (NYSE:MO) Inc said on Wednesday industry peer Philip Morris International Inc (NYSE:PM) has agreed to pay $2.7 billion for the exclusive right to sell IQOS heated tobacco products in the United States.
IQOS is a smokeless tobacco heating device that was developed by Philip Morris and sold in the United States by Altria until the U.S. trade regulator banned the import and sale of the product last year following patent claims from rival R.J. Reynolds.
Philip Morris is looking to overturn the ban.
Altria, which sells cigarette brands like Marlboro in the United States, was spun off from Philip Morris International in 2008 when the company wanted to separate its U.S. and overseas businesses.
Altria said one of its subsidiaries had an option to extend the IQOS contract until April 2029 after it had reached certain milestones. However, Philip Morris disagreed with Altria's position.
"The parties were unable to reach a long-term agreement and decided to enter into the Agreement to transition and ultimately conclude their relationship," Altria said in a statement.
Philip Morris, which reports quarterly results later on Thursday, aims to resume supply of IQOS products in the United States by the first half of 2023.
Altria still holds the rights to sell IQOS in the United States until May 2024, after which it transitions to Philip Morris.
"We are ready to invest behind IQOS to bring it to market at scale across the U.S.," Philip Morris Chief Executive Officer Jacek Olczak said.
Altria said it has already received $1 billion from Philip Morris and will receive the remainder by July 2023.
Separately, Philip Morris raised its buyout offer for Swedish Match AB in a last-ditch effort to get shareholder support for its $16 billion move into the fast-growing market for cigarettes alternatives.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.